Quarry LP Roivant Sciences Ltd. Transaction History
Quarry LP
- $398 Billion
- Q3 2024
A detailed history of Quarry LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Quarry LP holds 7,500 shares of ROIV stock, worth $91,125. This represents 0.02% of its overall portfolio holdings.
Number of Shares
7,500
Previous 5,000
50.0%
Holding current value
$91,125
Previous $52.9 Million
63.77%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding ROIV
# of Institutions
311Shares Held
508MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$801 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$799 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$657 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$506 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$430 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.56B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...